Literature DB >> 7151314

Mannosidosis in two brothers: prolonged survival in the severe phenotype.

M A Patton, I C Barnes, I D Young, P S Harper, C A Pennock.   

Abstract

Two cases of mannosidosis are reported in brothers, one aged 41 years at death, the other aged 40 years and still alive. These patients are the oldest reported in the literature. Prolonged survival has previously been associated with the milder Type II phenotype. In addition to the characteristic clinical and radiological features of mannosidosis, both had severe joint destruction, which may be related to abnormal lysosomal enzymes in cartilage. The activity of acidic alpha-mannosidase was markedly reduced in plasma, leucocytes and fibroblasts, and the altered kinetic and physical properties are described.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7151314     DOI: 10.1111/j.1399-0004.1982.tb01447.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  Neurology of adult alpha-mannosidosis.

Authors:  S Niemann; M Beck; G Seidel; J Spranger; P Vieregge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

2.  Cognitive profile and activities of daily living: 35 patients with alpha-mannosidosis.

Authors:  L Borgwardt; A M Thuesen; K J Olsen; J Fogh; C I Dali; A M Lund
Journal:  J Inherit Metab Dis       Date:  2015-05-28       Impact factor: 4.982

3.  Destructive joint disease in alpha-mannosidosis. A case report and review of the literature.

Authors:  A H Gerards; W P C A Winia; J Westerga; B A C Dijkmans; R M van Soesbergen
Journal:  Clin Rheumatol       Date:  2003-11-13       Impact factor: 2.980

4.  Spectrum of mutations in alpha-mannosidosis.

Authors:  T Berg; H M Riise; G M Hansen; D Malm; L Tranebjaerg; O K Tollersrud; O Nilssen
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

Review 5.  Mortality in patients with alpha-mannosidosis: a review of patients' data and the literature.

Authors:  Julia B Hennermann; Eva M Raebel; Francesca Donà; Marie-Line Jacquemont; Graziella Cefalo; Andrea Ballabeni; Dag Malm
Journal:  Orphanet J Rare Dis       Date:  2022-07-23       Impact factor: 4.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.